# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Citigroup analyst Andrew Kaplowitz maintains Xylem (NYSE:XYL) with a Buy and raises the price target from $168 to $173.
Berkshire agreed to buy OxyChem for $9.7 billion while EA goes private for $55 billion. Also, Middleby seeks a $800 million deal.
Xylem Inc. (NYSE:XYL), a leading global water solutions company, has entered into a definitive agreement for AURELIUS to acquir...
Barclays analyst William Grippin initiates coverage on Xylem (NYSE:XYL) with a Overweight rating and announces Price Target ...
Mizuho analyst Brett Linzey maintains Xylem (NYSE:XYL) with a Neutral and raises the price target from $125 to $140.